Sunnyvale, CA, United States of America

Mathieu Herbette

This inventor holds 2 USPTO granted patents. Top assignee: Alexza Pharmaceuticals, Inc.. Active years: 2009-2012.


% Patents Active = 50.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 171(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mathieu Herbette

Introduction

Mathieu Herbette is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of aerosol delivery devices, particularly in the medical sector. With a total of 2 patents, Herbette's work focuses on enhancing the delivery of substances, such as drugs, through innovative technologies.

Latest Patents

Herbette's latest patents include advancements in multiple dose condensation aerosol devices and methods of forming condensation aerosols. These devices and methods are designed to entrain a substance within an airflow, ensuring high purity and yield. The technology is characterized by a particle size distribution that is appropriate for pulmonary delivery, allowing for effective administration to users in a single dose.

Career Highlights

Currently, Mathieu Herbette is associated with Alexza Pharmaceuticals, Inc., where he continues to develop cutting-edge aerosol delivery systems. His work has the potential to revolutionize how medications are delivered, improving patient outcomes and enhancing the efficiency of drug administration.

Collaborations

Herbette collaborates with talented professionals in his field, including Andrew J. G. Kelly and Daniel J. Myers. These partnerships foster innovation and drive the development of new technologies in aerosol delivery.

Conclusion

Mathieu Herbette's contributions to aerosol delivery technology exemplify the impact of innovative thinking in the medical field. His patents and ongoing work at Alexza Pharmaceuticals, Inc. highlight the importance of advancements in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…